Welcome, Guest
Username: Password: Remember me
General
  • Page:
  • 1

TOPIC: Puregraft Royalty

Puregraft Royalty 30 Oct 2018 08:49 #12317

  • rodney.strongg
  • rodney.strongg's Avatar Topic Author
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 1362
  • Thank you received: 19
See news this morning re receipt of $1 million royalty from Bimini re prior divestiture of Puregraft product line.

Please Log in or Create an account to join the conversation.

Puregraft Royalty 30 Oct 2018 09:03 #12318

  • b767cpt
  • b767cpt's Avatar
  • Offline
  • Gold Boarder
  • Gold Boarder
  • Posts: 303
  • Thank you received: 4
Finally some revenue!

Please Log in or Create an account to join the conversation.

Puregraft Royalty 30 Oct 2018 09:05 #12319

  • fas
  • fas's Avatar
  • Offline
  • Moderator
  • Moderator
  • May the fat be with you
  • Posts: 3357
  • Thank you received: 1116

rodney.strongg wrote: See news this morning re receipt of $1 million royalty from Bimini re prior divestiture of Puregraft product line.


Well- all bits and pieces help- wonder what the gross revenue was on 10 Mio gross profit on Puregraft- my guess would be about 30-40 Mio, which would have been about 7 Mio annually. A lot more than what Cytori is selling these days.

Oct 30, 2018
SAN DIEGO, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (Nasdaq: CYTX) announced today it has received a milestone payment of $1.0 million from Bimini Technologies, LLC (Bimini). The payment is a result of Bimini achieving the first $10.0 million in gross profits for previous divestiture of the Puregraft® product line.

In 2013, Cytori entered into a Sale and Exclusive License/Supply Agreement with Bimini, pursuant to which Cytori sold to Bimini selected assets relating to Cytori’s Puregraft® product line, a series of standalone fat transplantation products that were developed to improve the predictability of outcomes for autologous fat grafting and aesthetic body contouring.

Bimini may also be obligated to make certain additional milestone payments to Cytori (in an aggregate amount of up to $10.0 million), contingent upon future achievement of certain milestones relating to Bimini’s gross profits from sales of the Puregraft products. The aggregate value of the consideration paid by Bimini to Cytori at the execution of the agreement in July 2013 was $5.0 million.

Please Log in or Create an account to join the conversation.

Board moderator and Site-owner. I still regret the day I started analysing the prospects of MacroPore (now Cytori) back in 2004- a left-over from the tech-bubble at that time from the century change in my portfolio- and became addicted to Cytori´s fat cell technology. :cry:

Puregraft Royalty 30 Oct 2018 09:35 #12320

  • rodney.strongg
  • rodney.strongg's Avatar Topic Author
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 1362
  • Thank you received: 19

fas wrote:

rodney.strongg wrote: See news this morning re receipt of $1 million royalty from Bimini re prior divestiture of Puregraft product line.


Well- all bits and pieces help- wonder what the gross revenue was on 10 Mio gross profit on Puregraft- my guess would be about 30-40 Mio, which would have been about 7 Mio annually. A lot more than what Cytori is selling these days.

Oct 30, 2018
SAN DIEGO, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (Nasdaq: CYTX) announced today it has received a milestone payment of $1.0 million from Bimini Technologies, LLC (Bimini). The payment is a result of Bimini achieving the first $10.0 million in gross profits for previous divestiture of the Puregraft® product line.

In 2013, Cytori entered into a Sale and Exclusive License/Supply Agreement with Bimini, pursuant to which Cytori sold to Bimini selected assets relating to Cytori’s Puregraft® product line, a series of standalone fat transplantation products that were developed to improve the predictability of outcomes for autologous fat grafting and aesthetic body contouring.

Bimini may also be obligated to make certain additional milestone payments to Cytori (in an aggregate amount of up to $10.0 million), contingent upon future achievement of certain milestones relating to Bimini’s gross profits from sales of the Puregraft products. The aggregate value of the consideration paid by Bimini to Cytori at the execution of the agreement in July 2013 was $5.0 million.

/

Apparently took Bimini about 5 years to achieve the $10 million - nevertheless, it appears that it may have been better for CYTX to never have sold the product line assuming they could have achieved similar results as Bimini - their market cap would certainly have been higher imo.

Please Log in or Create an account to join the conversation.

  • Page:
  • 1
Time to create page: 0.064 seconds

Copyright Information

Copyright Fas Kuiters © 2016 young-foxes.com. All Rights Reserved.
This page is made with Joomla CMS and its various templates designed by Fas Kuiters with the excellent Themler tool.

 

 

Shared Spreadsheet Links

DOV´s Revised Projections for the Periods 2017 until 2020

Shareble link : HERE

Fas Kuiters Websites